Hipering® Technology Transforms Challenging Powders Into Clean-Label Performance
 

In today's supplement market, manufacturers are increasingly seeking delivery technologies that improve dosage convenience, bioavailability, and production consistency while minimizing formulation complexity. Industry reports continue to highlight growing demand for technologies that enhance nutrient delivery, optimize flowability, and reduce "pill fatigue" through smaller dosage forms.

Addressing these challenges, Hipering®, a patented granulation technology, offers a novel solution for transforming difficult fine powders into free-flowing, compressible granules without the use of synthetic binders, fillers, solvents, or excipients. The technology improves rheological behavior, enhances tablet manufacturability, and reduces operational inefficiencies while preserving the original ingredient chemistry and stability profile.


What is Hipering®?

How It Works: Advanced Granulation Without Chemical Modification

Unlike many conventional granulation systems that rely on binders or excipient systems, Hipering® technology granulates powders into free-flowing granules without the use of excipients, while preserving ingredient purity and chemical integrity. The technology consists of a proprietary dry granulation process, followed by a compaction process that together physically transforms fine powder particles into stable, uniform granules. During processing, powders are compressed into ribbons and subsequently milled into controlled granules through sequential stages including particle rearrangement, deformation, fragmentation, and bonding.

HIPERING® process: deaeration, particle rearrangement, particle deformation, particle fragmentation, particle bonding — no chemical changes, no regulatory changes

These processes improve bulk density, compressibility, and particle size uniformity while preserving the ingredient's original chemical identity and HPLC profile. No chemical or regulatory changes occur during processing, allowing immediate dossier incorporation and maintaining ingredient stability and shelf life.

HIPERING® API versus conventional API and particle size distribution graph

The resulting granules deliver superior rheological performance by improving powder flowability, minimizing machine adhesion, and increasing manufacturing efficiency. In select applications—for example, melatonin—the technology can also enhance dissolution and water interaction through increased surface area, resulting in improved solubility and greater formulation versatility. Complementing this approach, Hipering® utilizes an AI-driven optimization matrix to identify customized granulation parameters tailored to the unique physical and structural properties of each ingredient.


Performance Evidence

Real-world case studies demonstrate substantial improvements in flowability, compressibility, and manufacturing efficiency after Hipering® processing.

Case Study #2: Rhamnus frangula or Frangula Bark

Additional data presented for the botanical alder buckthorn; Rhamnus frangula demonstrated similar performance optimization following Hipering® treatment. The processed material showed improved particle size distribution uniformity and enhanced rheological characteristics that support smoother production runs and reduced material waste.

Standard Rhamnus frangula powder compared with HIPERING® processed Rhamnus frangula granules

Production Results

  • 38% improvement in compressibility index
  • 68% improvement in flowability
  • 54% improvement in angle of repose
  • Enhanced particle size distribution uniformity

Operational & Manufacturing Benefits

Research demonstrates that Hipering® can deliver meaningful improvements in manufacturing efficiency and product performance, including:

50–60% increase in production efficiency and manufacturing yield
Up to 40% reduction in operational costs
Up to 45% reduction in packaging volume through more compact dosage forms
Enhanced tablet quality — improved hardness, reduced friability, and optimized disintegration
Capsule size reduction: from 0.15 g/ml density, size 22 oblong, 1.5 g weight to 0.65 g/ml density, size 10 oval, 0.87 g weight

Formulation & Delivery Format Advantages

Hipering® is a versatile granulation technology compatible with a wide range of nutraceutical and botanical ingredients, including CoQ10, melatonin, quercetin, magnesium citrate, L-tryptophan, and numerous plant extracts. Its excipient-free process improves powder flowability, tablet compression, capsule filling, and dissolution performance while preserving the ingredient's native chemistry.

By increasing bulk density and enabling higher active ingredient loading, Hipering® can significantly reduce tablet and capsule size without compromising potency. The result is more compact dosage forms that help address consumer pill fatigue, improve swallowing convenience, and support better compliance. At the same time, the technology simplifies manufacturing by overcoming common formulation challenges associated with poor flowability, low bulk density, particle aggregation, and difficult-to-compress ingredients.


Differentiation & Competitive Advantage

Hipering® incorporates an AI-driven optimization platform that analyzes the unique physical and structural properties of each active ingredient to identify the most effective granulation strategy. This customized approach streamlines formulation development, improves manufacturing efficiency, and helps achieve consistent product quality across a broad range of ingredient types.

HIPERING® AI optimization workflow: predictive AI engine moving through input, matching, prediction, and optimization stages

Explore how Hipering® technology can optimize your formulation and manufacturing efficiency. Contact us today to discuss excipient-free granulation solutions for your operation.

Ready to elevate your ingredient performance? Partner with us to apply Hipering® technology to your formulation and unlock clean-label, excipient-free manufacturing advantages.

Ask us about Hipering®

Contact Us